Chikungunya is not endemic in the EU/EEA and the majority of the cases are travellers infected outside of the EU/EEA. When the environmental conditions are favourable, in areas where Ae. albopictus is established, viraemic travel-related cases may generate a local transmission of the virus as demonstrated by the sporadic events of chikungunya virus transmission since 2007.
Chikungunya is a viral disease transmitted by Aedes mosquitoes to humans. The word ‘chikungunya’ means 'that which bends up', an allusion to the posture of the suffering patients. The most common symptom is joint pain.
On 14-15 January 2015 an ECDC consultation gathered public health experts, entomologists and epidemiologists from Europe, as well as experts from WHO, CDC and PacNet, to review the EU preparedness to dengue and chikungunya importation and onwards transmission and produce a roadmap towards improved EU preparedness.
Severe acute respiratory syndrome (SARS) is a life-threatening respiratory disease caused by a recently identified coronavirus; the SARS-associated coronavirus (SARS-CoV). This is believed to be an animal virus that recently crossed the species barrier to infect humans.
An outbreak of chikungunya in the Caribbean region was reported from the French part of the island of Saint Martin on 6 December 2013. Since then, autochthonous transmission of chikungunya has been reported from several islands in the Caribbean. For the first time, local cases of chikungunya were reported in South America (French Guiana).